Smart insulin pump could ease diabetes after pancreas surgery

NCT ID NCT07430293

Recruiting now Disease control Sponsor: Centre Hospitalier Sud Francilien Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study tests whether a hybrid closed-loop insulin pump (MiniMed 780) can help people with diabetes after pancreas removal achieve better blood sugar control. About 24 adults will use the pump for 3 months and then their usual treatment for 3 months, with results compared. The goal is to see if the automated system increases time blood sugar stays in a healthy range and improves quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES AFTER PANCREATECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus post-surgical hypoinsulinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATECTOMY PARTIAL PANCREATECTOMY TOTAL PANCREATECTOMY

Contacts and locations

Locations

Centre Hospitalier Sud Francilien
RECRUITING

Corbeil-Essonnes, France, 91100, France
Hôpital Bichat (APHP)
NOT_YET_RECRUITING

Paris, France, 75018, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.